Systematic review and meta-analysis of immunotherapy effectiveness for pretreated patients with non-small cell lung cancer harboring EGFR exon 20 insertions

被引：5

作者：

Christopoulos, P. ^{[1
,2
,3
]}

Ou, S-H. I. ^{[4
]}

Lin, J. ^{[5
,6
,10
]}

Berg, D. ^{[6
,7
]}

Hong, J-L. ^{[6
,8
]}

Yin, Y. ^{[6
,9
]}

Lin, J. ^{[5
,6
,10
]}

Bunn, V. ^{[6
,11
]}

Lin, H. M. ^{[6
,11
]}

Mehta, M. ^{[6
,12
]}

Thomas, M. ^{[1
,2
,3
,6
]}

机构：

[1] Heidelberg Univ Hosp, Dept Thorac Oncol, Thoraxklin & Natl Ctr Tumor Dis eases, Heidelberg, Germany

[2] Translat Lung Res Ctr Heidel berg TLRC H, Heidelberg, Germany

[3] German Ctr Lung Res DZL, Heidelberg, Germany

[4] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Sch Med, Orange, CA USA

[5] Millennium Pharmaceut Inc, Stat, Cambridge, MA USA

[6] Takeda Pharmaceut Co Ltd, Cambridge, England

[7] Millennium Pharmaceut Inc, Oncol Res & Dev, Cambridge, MA USA

[8] Millennium Pharmaceut Inc, Epidemiol, Cambridge, MA USA

[9] Millennium Pharmaceut Inc, Observat Res Analyt, Cambridge, MA USA

[10] Millennium Pharmaceut Inc, Oncol Stat, Cambridge, MA USA

[11] Millennium Pharmaceut Inc, Global Evidence & Outcome, Cambridge, MA USA

[12] Millennium Pharmaceut Inc, Clin Sci, Cambridge, MA USA

来源：

关键词：

D O I：

10.1016/j.annonc.2021.08.1829

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1224P

引用

页码：S972 / S972

页数：1